Search | Schedule | Concurrent Oral Session Grid | Author Index | eBook | Personal Scheduler

Author Index: W

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Wald, H.
COMPARATIVE EFFECTIVENESS OF QUALITY IMPROVEMENT INTERVENTIONS FOR PRESSURE ULCER PREVENTION IN HOSPITALS
Walensky, R. P.
F-2   MODELING HIV TRANSMISSION DYNAMICS IN CONJUNCTION WITH A MICROSIMULATION OF DISEASE PROGRESSION
Walker, C. M.
TRANSLATION AND APPLICATION OF THE NUMERACY UNDERSTANDING IN MEDICINE INSTRUMENT IN JAPAN
Walter, D.
ARE HOSPITALS “KEEPING UP WITH THE JONESES”?: ASSESSING THE SPATIAL AND TEMPORAL DIFFUSION OF THE SURGICAL ROBOT

COMPLICATIONS ASSOCIATED WITH NEW RADIOTHERAPY TECHNOLOGY

N-1   THE EFFECT OF THE DIFFUSION OF THE SURGICAL ROBOT ON THE HOSPITAL-LEVEL UTILIZATION OF PARTIAL NEPHRECTOMY
Walter, S.
HOW TO DESIGN A RANDOMISED TRIAL FOR THE ESTIMATION OF TREATMENT, SELECTION AND PREFERENCE EFFECTS
Wang, D. Y.
AUTOMATING QUALITY REVIEW FOR HEART FAILURE THROUGH A PERFORMANCE MEASUREMENT SYSTEM
Wang, D.
MISPERCEPTION OF CANCER RISK IN PATIENTS WITH NEUROFIBROMATOSIS 1 AND 2
Wang, G.
A-1   10/18- PRESENTATION CANCELLED - HOSPITALIZATION COSTS ASSOCIATED WITH ATRIAL FIBRILLATION FOR PATIENTS OF ISCHEMIC STROKE IN THE UNITED STATES
Wang, J.
O-3   MAKING THE MOST OF LIMITED DATA WITH UNCERTAINTY USING PROBABILISTIC ANALYSES: A CASE STUDY IN ONCOLOGY
Wang, X.
A-3   CHARACTERISTICS OF MULTI-DISCIPLINARY HEART FAILURE CLINICS THAT PREDICT 1-YEAR CUMULATIVE HEALTH CARE COSTS: A POPULATION-BASED STUDY
Wang, Y. C.
COMMITTEE & INTEREST GROUP MEETINGS: TEACHING MDM INTEREST GROUP

F-3   CALIBRATION OF A MARKOV CARDIOVASCULAR DISEASE MICROSIMULATION MODEL USING AN ESTABLISHED CELL-BASED SIMULATION MODEL
Watson, P. R.
VALUING TRIAL DESIGNS FROM A PHARMACEUTICAL PERSPECTIVE USING VALUE-BASED PRICING
Weatherly, H.
I-2   ESTIMATING THE CLINICAL AND QUALITY OF LIFE BENEFITS OF ACUPUNCTURE FROM MULTIPLE PATIENT LEVEL DATA SOURCES: WHAT A PAIN!
Weber, T. A.
O-1   OPTIMAL INFORMATION ACQUISITION POLICIES WITH PARAMETERS THAT VARY ACROSS INTERVENTION COHORTS: APPLICATION TO HCV SCREENING
Weersing, V. R.
LONGER-TERM COST-EFFECTIVENESS OF A COGNITIVE-BEHAVIORAL PROGRAM FOR PREVENTING DEPRESSION IN AT-RISK ADOLESCENTS
Wei, J. T.
J-1   RACIAL DIFFERENCES IN TREATMENT PREFERENCES AFTER USING A LOW VERSUS HIGH LITERACY PROSTATE CANCER DECISION AID
Wei, W.
MUCH ADO ABOUT NOTHING? A LONGITUDINAL RETROSPECTIVE STUDY OF PATIENTS WITH TYPE-2 DIABETES TREATED WITH INSULIN GLARGINE AND SWITCHED TO INSULIN DETEMIR
Weil, A. M.
TRA1-5   EFFICACY OF THE BRCA GIST INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK
Weinstein, M. C.
MEMORIAL TRIBUTE TO JANE C. WEEKS, M.D., M.SC.

COST-EFFECTIVENESS OF INTERSPINOUS SPACER DEVICES IN THE SURGICAL TREATMENT OF LUMBAR SPINAL STENOSIS

IMPACT OF THE RATE OF RESCUE PERCUTANEOUS CORONARY INTERVENTION AFTER THROMBOLYSIS ON THE COST-EFFECTIVENESS OF ACUTE STEMI MANAGEMENT STRATEGIES FOR NON-URBAN COMMUNITIES

F-2   MODELING HIV TRANSMISSION DYNAMICS IN CONJUNCTION WITH A MICROSIMULATION OF DISEASE PROGRESSION
Weis, E.
TECHNOLOGY USE AMONGST PATIENTS WITH AGE-RELATED MACULAR DEGENERATION IN ALBERTA, CANADA
Welch, A.
DOES DOXYCYCLINE REDUCE THE RISK OF CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH CELLULITIS?
Welton, N. J.
ACCOUNTING FOR HETEROGENEITY IN COST-EFFECTIVENESS ANALYSIS AND VALUE OF INFORMATION ANALYSIS: IVIG FOR SEVERE SEPSIS

EXTRAPOLATION OF TRIAL-BASED SURVIVAL CURVES: CONSTRAINTS BASED ON EXTERNAL INFORMATION

EVIDENCE SYNTHESIS FOR DECISION MAKING

I-4   STRATEGIES FOR CALCULATING EVPPI EFFICIENTLY

L-3   OPTIMAL DESIGN OF NEW RESEARCH WHEN THERE ARE MULTIPLE COMPETING HEALTH TECHNOLOGIES: HOW MANY ARMS, AND WHICH TREATMENTS?
Wheeler, S. B.
B-2   UNDERSTANDING PREFERENCES FOR CRC SCREENING PROGRAMS AMONG VULNERABLE ADULTS IN RURAL NORTH CAROLINA: A DISCRETE CHOICE EXPERIMENT
Whellan, D.
M-3   DEVELOPMENT OF A WEB-BASED SIMULATION TOOL TO MODEL COST-EFFECTIVENESS OF DISEASE MANAGEMENT PROGRAMS IN CHRONIC HEART FAILURE
White, C. D.
SYMPOSIUM: BRIDGING MEDICAL DECISION MODELING AND HEALTH CARE POLICY: AN EXCHANGE BETWEEN DECISION MODELERS AND POLICYMAKERS
Whitehead, M. M.
PATIENT-PROVIDER CONVERSATIONS ABOUT ADVANCE CARE PLANNING
Whyte, R.
DECIDING TO UNDERGO A TRIAL OF LABOR AFTER A PREVIOUS CESAREAN: SOURCES OF INFLUENCE
Widmer, C. L.
TRA1-5   EFFICACY OF THE BRCA GIST INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK
Wijburg, C.
B-3   EFFECT OF A PATIENT DECISION AID FOR PROSTATE CANCER ON DIFFERENT ASPECTS OF REGRET: A RANDOMIZED, CONTROLLED TRIAL
Wijeysundera, H. C.
A-3   CHARACTERISTICS OF MULTI-DISCIPLINARY HEART FAILURE CLINICS THAT PREDICT 1-YEAR CUMULATIVE HEALTH CARE COSTS: A POPULATION-BASED STUDY

TRA1-3   IMPACT OF INCREASING WAIT TIMES ON THE EFFECTIVENESS OF TRANSCATHETER AORTIC-VALVE REPLACEMENT (TAVR) IN HIGH-RISK AND INOPERABLE PATIENTS WITH SEVERE AORTIC DISEASE: A DISCRETE EVENT SIMULATION MODEL
Wijnhoven, B. P. L.
H-3   COMPARING SURGICAL PERFORMANCE FOR ESOPHAGECTOMY: HOW LONG SHOULD WE FOLLOW-UP?
Wilhelms, E. A.
DO NUMBERS MAKE A DIFFERENCE?
Wilkie, M.
ASSESSING THE ACCEPTABILITY OF THE YORKSHIRE DIALYSIS DECISION AID TO PATIENTS

SHOULD PATIENT NARRATIVES BE USED TO SUPPORT PEOPLE'S TREATMENT DECISION MAKING: AN EXPERIMENTAL STUDY ABOUT DIALYSIS OPTIONS?
Willan, A. R.
USING VALUE OF INFORMATION METHODS WHEN THE DISEASE IS RARE AND THE TREATMENT IS EXPENSIVE – THE EXAMPLE OF HEMOPHILIA A

COST-EFFECTIVENESS OF EDUCATION AND ACTIVATION, AND A REHABILITATION PROGRAM, COMPARED TO THE LEGISLATED STANDARD OF CARE FOR ACUTE WHIPLASH INJURY IN ONTARIO
Willenbacher, W.
METHODOLOGICAL CHARACTERISTICS OF DECISION-ANALYTIC MODELING STUDIES FOR THE TREATMENT OF MULTIPLE MYELOMA
Williams, K. D.
PHYSICIANS PREFERENTIALLY SEEK INFORMATION FOR CLINICAL DECISIONS FROM COLLEAGUES VERSUS OTHER SOURCES
Williams, R.
ESTIMATING COSTS IN A COMPLEX HEALTHCARE ENVIRONMENT
Williamson, J.
EFFECTIVENESS OF A CLINICAL REASONING CURRICULUM TO IMPROVE KNOWLEDGE OF APPROPRIATE ANTIBIOTIC USE
Williamson, P.
G-6   USING A MODEL-BASED ECONOMIC EVALUATION IN A FEASIBILITY STUDY TO INFORM THE VALUE OF A FUTURE TRIAL: A CASE STUDY OF GROMMETS-INSERTION FOR CHILDREN WITH CLEFT PALATE AFFECTED BY OTITIS MEDIA WITH EFFUSION
Wilson, L.
NEW THERAPEUTIC OPTIONS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): CAN COST-EFFECTIVENESS ANALYSIS HELP IN TREATMENT DECISION?
Winterbottom, A.
ASSESSING THE ACCEPTABILITY OF THE YORKSHIRE DIALYSIS DECISION AID TO PATIENTS

SHOULD PATIENT NARRATIVES BE USED TO SUPPORT PEOPLE'S TREATMENT DECISION MAKING: AN EXPERIMENTAL STUDY ABOUT DIALYSIS OPTIONS?
Wisloff, T.
USING MODELING TO MAKE BETTER MEDICAL DECISIONS
Wisløff, T.
A PARADIGM SHIFT IN ANTICOAGULATION OR TOO SOON TO CONCLUDE ON COST-EFFECTIVENESS OF NEW ORAL ANTICOOAGULANTS?

C-5   DO WE NEED COMPARATIVE EFFECTIVENESS RESEARCH ON THE NEW ORAL ANTICOAGULANTS?
Wisniewski, S. R.
BASING TREATMENT RECOMMENDATIONS IN RHEUMATOID ARTHRITIS ON PATIENTS' RATHER THAN PHYSICIANS' JOINT ASSESSMENTS
Witjes, J. A.
B-3   EFFECT OF A PATIENT DECISION AID FOR PROSTATE CANCER ON DIFFERENT ASPECTS OF REGRET: A RANDOMIZED, CONTROLLED TRIAL
Witteman, H. O.
COMMITTEE & INTEREST GROUP MEETINGS: IMPLEMENTATION SCIENCE & KNOWLEDGE TRANSLATION INTEREST GROUP

E-5   ABILITY TO IDENTIFY OUT-OF-RANGE TEST RESULTS IN STANDARD TABLES IS HIGHLY DEPENDENT ON NUMERACY

K-4   SUPPORTING PATIENT VALUES: A SYSTEMATIC REVIEW OF VALUES CLARIFICATION EXERCISES

K-6   FAITH IN DELIBERATION: ON THE IMPACT OF DELIBERATIVE VERSUS INTUITIVE STRATEGIES ON PATIENT DECISIONS

TRIALS AND INTERVENTIONS FOR RISK REDUCTION

INTRODUCTION TO DESIGNING EVIDENCE-BASED PATIENT DECISION AIDS

TRA2-1   FOLLOW THE CROWD: HOW SOCIAL MEDIA COMMENTS ON HEALTH NEWS ARTICLES INFLUENCE OPINIONS ABOUT HEALTH CHOICES
Wittenberg, E.
IMPACT OF ILLICIT DRUG USE ON HEALTH UTILITY IN OPIOID DEPENDENT PATIENTS RECEIVING HIV TREATMENT

HOMELESS WOMEN'S DECISION COMPONENTS FOR CERVICAL CANCER SCREENING: ATTRIBUTES AND LEVELS FOR A DISCRETE CHOICE EXPERIMENT

ESTIMATING HETEROGENEITY IN THE SECONDARY IMPACT OF CHRONIC ILLNESS ON THE RATING SCALE VALUES OF FAMILY MEMBERS

TOP-RANKED ABSTRACTS, CONCURRENT SESSION 1
Wolf, D.
COST-EFFECTIVENESS ANALYSIS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
Wolfe, C. R.
IMPROVING DECISIONS FOR CANCER CARE

TRA1-5   EFFICACY OF THE BRCA GIST INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK
Wong, J.
LEE B. LUSTED CANDIDATES’ MODERATED POSTER SESSION (CLOSED SESSION)

SMDM EARLY CAREER AWARDS
Wong, W. W. L.
I-6   USING PROJECTIONS OF LIFE EXPECTANCY IN ECONOMIC DECISION MAKING

N-6   THE HEPATITIS C DRUG PIPELINE: COLLABORATION BETWEEN ACADEMIC AND HTA AGENCY PARTNERS TO DEVELOP AN EARLY ECONOMIC MODEL

TRA1-3   IMPACT OF INCREASING WAIT TIMES ON THE EFFECTIVENESS OF TRANSCATHETER AORTIC-VALVE REPLACEMENT (TAVR) IN HIGH-RISK AND INOPERABLE PATIENTS WITH SEVERE AORTIC DISEASE: A DISCRETE EVENT SIMULATION MODEL
Wong, Y. N.
FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS
Wright, D. R.
METHODS FOR OPTIMIZING AND ANALYZING PATIENT OUTCOMES
Wright, T. C. Jr.
D-1   CERVICAL CANCER SCREENING IN RESOURCE-LIMITED SETTINGS: EVALUATING TRADEOFFS BETWEEN TEST PERFORMANCE AND PROGRAMMATIC CONSIDERATIONS
Wu, V.
EFFECT OF WEIGHT LOSS INDUCED BY PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE ON ANNUAL MEDICATION COSTS IN OBESE AND OVERWEIGHT INDIVIDUALS

CHANGES IN ANNUAL MEDICATION COSTS ASSOCIATED WITH WEIGHT LOSS INDUCED BY PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE ACROSS BODY-MASS INDEX LEVELS IN OBESE AND OVERWEIGHT INDIVIDUALS

N-3   EFFECT OF MAGNITUDE OF WEIGHT LOSS ON ANNUAL ANTIHYPERTENSIVE, LIPID-LOWERING, AND ANTIDIABETIC MEDICATION COST IN OBESE AND OVERWEIGHT INDIVIDUALS
Wu, Y.
L-5   IMPROVING BIOPSY RECOMMENDATIONS FOLLOWING MAMMOGRAPHY USING RANDOM FORESTS
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z